Biofrontera (BFRI) Total Current Liabilities (2020 - 2025)

Biofrontera's Total Current Liabilities history runs 6 years deep, the most recent figure standing at $11.9 million for Q4 2025.

• On a quarterly basis, Total Current Liabilities fell 1.05% year-over-year to $11.9 million in Q4 2025; TTM through Dec 2025 was $11.9 million, a 1.05% decrease from a year earlier, with the FY2025 full-year figure at $11.9 million, down 1.05% from the prior year.
• Total Current Liabilities eased to $11.9 million in Q4 2025 per BFRI's latest filing, from $12.6 million in the prior quarter.
• Across five years, Total Current Liabilities topped out at $29.1 million in Q3 2023 and bottomed at $9.3 million in Q2 2024.
• The 5-year median for Total Current Liabilities is $13.8 million (2021), against an average of $15.3 million.
• Across the five-year window, Total Current Liabilities surged 213.03% in 2021 and plunged 62.12% in 2024, its largest moves.
• Year by year, Total Current Liabilities stood at $13.8 million in 2021, then soared by 51.01% to $20.9 million in 2022, then retreated by 13.43% to $18.1 million in 2023, then plunged by 33.54% to $12.0 million in 2024, then fell by 1.05% to $11.9 million in 2025.
• Per Business Quant, the three latest BFRI Total Current Liabilities figures stand at $11.9 million (Q4 2025), $12.6 million (Q3 2025), and $19.7 million (Q2 2025).